Literature DB >> 11198495

Neurologic symptoms in children with systemic lupus erythematosus.

A I Quintero-Del-Rio1.   

Abstract

Neurologic complications of systemic lupus cerebritis are not as well known in children as in adults. Twenty-five children with neurologic complications were identified after reviewing the hospital medical records of 86 children with systemic lupus erythematosus. Seven children (28%) had neurologic symptoms at the time of initial diagnosis of systemic lupus erythematosus; median time between diagnosis of systemic lupus erythematosus and onset of neurologic complications was 1 month (range 0-5 years). Seizures were the most common neurologic symptoms overall, but headaches were the most frequent neurologic manifestation in children without a previous diagnosis of systemic lupus erythematosus. Sixteen children had seizures, and 12 children had seizures as the initial central nervous system involvement. Almost all children who developed seizures had an established diagnosis of systemic lupus erythematosus; only one child had seizures that led to the diagnosis of systemic lupus erythematosus. No patient had status epilepticus, and, in general, seizures were not difficult to control. In six children, headache was the initial symptom of central nervous system involvement. Five children had lupus cerebritis, three children had stroke, and two had isolated cranial neuropathies. Chorea was seen in only two cases, and three children had pseudotumor cerebri. Treatment with high-dose intravenous methylprednisolone led to a good response in 18 children; cyclophosphamide was required in 6 patients and plasmapheresis in 1 child. Outcome was generally good, although one child developed fulminant cerebritis with intracranial hypertension and died.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11198495     DOI: 10.1177/088307380001501207

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  10 in total

Review 1.  Pediatric antiphospholipid syndrome.

Authors:  Jacqueline A Madison; Yu Zuo; Jason S Knight
Journal:  Eur J Rheumatol       Date:  2019-12-03

2.  Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus.

Authors:  Mohamed O Olfat; Sulaiman M Al-Mayouf; Mohamed A Muzaffer
Journal:  Clin Rheumatol       Date:  2004-07-23       Impact factor: 2.980

Review 3.  Understanding the epidemiology and progression of systemic lupus erythematosus.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Lacie Scofield; Leslie Reinlib; Glinda S Cooper
Journal:  Semin Arthritis Rheum       Date:  2009-01-10       Impact factor: 5.532

4.  Life-threatening extrarenal lupus in children despite improvement in serologic findings.

Authors:  Lavjay Butani; Sudesh P Makker
Journal:  Rheumatol Int       Date:  2003-02-05       Impact factor: 2.631

5.  Chorea as the first and only manifestation of systemic lupus erythematosus.

Authors:  Abdul Razzakh Poil; Fahmi Yousef Khan; Abdo Lutf; Mohammed Hammoudeh
Journal:  Case Rep Rheumatol       Date:  2012-09-16

6.  Intracranial hypertension: A rare presentation of lupus nephritis.

Authors:  Praveen Yadav; Anishkumar Nair; Ajith Cherian; N S Sibi; Ashwini Kumar
Journal:  J Pediatr Neurosci       Date:  2010-07

7.  Systemic lupus erythematosus presenting with status epilepticus and acute cardiomyopathy with acute heart failure: case report.

Authors:  H M M T B Herath; Aruna Kulatunga
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2020-01-29

Review 8.  Application of Plasma Exchange in Steroid-Responsive Encephalopathy.

Authors:  Yuting Jiang; Xin Tian; Yixue Gu; Feng Li; Xuefeng Wang
Journal:  Front Immunol       Date:  2019-02-27       Impact factor: 7.561

9.  An unusual presentation of lupus in a pediatric patient.

Authors:  Vimal Master Sankar Raj
Journal:  Case Rep Pediatr       Date:  2013-08-27

10.  Neuropsychiatric Involvement in Juvenile-Onset Systemic Lupus Erythematosus.

Authors:  Mohammad-Amin Khajezadeh; Gholamreza Zamani; Bobak Moazzami; Zahra Nagahi; Mahdie Mousavi-Torshizi; Vahid Ziaee
Journal:  Neurol Res Int       Date:  2018-05-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.